Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients

doi:10.4254/wjh.v11.i12.761

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8610)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

622

WORD

251

HTML

4704

Figures (1-2)

275

Tables (1-3)

258

Sum=6110

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

785

Download

1715

Sum=2500

Dec 27, 2019 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (34)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Dec 27, 2019; 11(12): 761-772
Published online Dec 27, 2019. doi: 10.4254/wjh.v11.i12.761

Full Size Figure Download Figure

Figure 1 Consort diagram. Consort diagram for the study. Modulator refers to lumacaftor/ivacaftor use. CF: Cystic fibrosis, MRI: Magnetic resonance imaging; CFTR: Cystic fibrosis transmembrane conductance regulator.

Citation: Kutney K, Donnola SB, Flask CA, Gubitosi-Klug R, O’Riordan M, McBennett K, Sferra TJ, Kaminski B. Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients. World J Hepatol 2019; 11(12): 761-772
URL: https://www.wjgnet.com/1948-5182/full/v11/i12/761.htm
DOI: https://dx.doi.org/10.4254/wjh.v11.i12.761